K. Marker

发表

Seminal plasma contains “BPSA,” a molecular form of prostate‐specific antigen that is associated with benign prostatic hyperplasia

K. Slawin, L. Marks, S. Mikolajczyk, 2000, The Prostate.

A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.

P. Carpenter, M. Saedi, S. Mikolajczyk, 2001, Cancer research.

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women

E. Ziv, H. Gómez, T. Vidaurre, 2020, Cancer Research.

COVID-19 Surveillance in the Biobank at the Colorado Center for Personalized Medicine: Observational Study

K. Barnes, C. Gignoux, J. Lowery, 2022, medRxiv.

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.

W. Catalona, S. Mikolajczyk, H. Rittenhouse, 2004, Clinical chemistry.

Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.

D. Tindall, R. Wolfert, L. Marks, 1999, Cancer research.

Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

M. Saedi, S. Mikolajczyk, L. Grauer, 1997, European journal of biochemistry.

A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women

Christopher A Haiman, Susan L Neuhausen, Donglei Hu, 2019, Journal of the National Cancer Institute.

A polygenic risk score for breast cancer in U.S. Latinas and Latin-American women

Christopher A. Haiman, Luis G. Carvajal-Carmona, Lawrence H. Kushi, 2019, bioRxiv.

Human kallikrein 2 (hK2), but not prostate‐specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI‐6) released from prostate carcinoma cells

P. Carpenter, M. Saedi, S. Mikolajczyk, 2001, International journal of cancer.

A dual‐monoclonal sandwich assay for prostate‐specific membrane antigen: Levels in tissues, seminal fluid and urine

R L Sokoloff, K C Norton, C L Gasior, 2000, The Prostate.